Independent predictors identified include Carcinoembryonic Antigen (CEA) levels, lymph node metastasis detected by PET/CT, and total lesion glycolysis (57). This evidence concerns the gene CEACAM5 and metastatic malignant neoplasm in the lymph nodes.